Description
Description: Brilique 90 mg is an oral antiplatelet medication indicated for the prevention of atherothrombotic events in adults. It is particularly used in patients with acute coronary syndromes (ACS) or those with a history of myocardial infarction (heart attack) who are at high risk for future cardiovascular events. Ticagrelor works by inhibiting platelet activation and aggregation, thereby reducing the risk of blood clots that can lead to heart attacks or strokes.
Key Benefits:
- Prevents Blood Clots: Reduces the likelihood of thrombotic events such as heart attacks and strokes.
- Effective in Acute Coronary Syndromes: Provides crucial management for patients experiencing ACS.
- Long-term Treatment Option: Can be used for extended treatment after initial therapy, particularly in high-risk patients.
Uses:
Brilique 90 mg is indicated for:
- Prevention of atherothrombotic events in adults with acute coronary syndrome (ACS).
- Patients with a history of myocardial infarction at high risk of developing further cardiovascular issues.
Dosage:
- Initial Dose: A loading dose of 180 mg (two 90 mg tablets) should be taken at the start of treatment.
- Maintenance Dose: After the initial dose, the recommended maintenance dose is 90 mg taken twice daily, typically for up to 12 months unless otherwise directed by a healthcare provider.
Side Effects:
Common Side Effects:
- Dyspnea (shortness of breath)
- Bleeding tendencies (increased risk of bleeding)
Serious Side Effects:
- Severe allergic reactions
- Gastrointestinal bleeding
- Intracranial hemorrhage
Precautions:
- Brilique should be used cautiously in patients with active bleeding disorders or severe liver impairment.
- Patients are advised to take Brilique in conjunction with aspirin, as directed by their healthcare provider.
- Regular monitoring is recommended to assess for any potential side effects, particularly bleeding.
There are no reviews yet.